Tenaya Therapeutics (TNYA) Other Accumulated Expenses (2020 - 2026)
Tenaya Therapeutics' quarterly Other Accumulated Expenses came in at $455000.0 in Q1 2026, up 30.0% year-on-year from $350000.0 in Q1 2025, and up 158.52% quarter-over-quarter from $176000.0 in Q4 2025.
Tenaya Therapeutics has reported Other Accumulated Expenses for 7 years, with the latest figure at $455000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 30.0% year-over-year to $455000.0; the trailing twelve-month figure through Mar 2026 stood at $455000.0 (up 30.0% YoY), and the FY2025 full-year result was $176000.0, down 17.76% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $455000.0, up from $176000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $833000.0 in Q1 2024, with the low at $142000.0 in Q2 2025.
- Average Other Accumulated Expenses over 5 years is $463117.6, with a median of $458000.0 recorded in 2023.
- Year-over-year, Other Accumulated Expenses jumped 236.42% in 2022 and plunged 63.75% in 2024.
- Tracing TNYA's Other Accumulated Expenses over 5 years: stood at $545000.0 in 2022, then retreated by 12.29% to $478000.0 in 2023, then sank by 55.23% to $214000.0 in 2024, then slipped by 17.76% to $176000.0 in 2025, then surged by 158.52% to $455000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $455000.0 (Q1 2026), $176000.0 (Q4 2025), and $186000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 455,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 350,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 833,000.00 |
| Dec 31, 2023 | 478,000.00 |
| Sep 30, 2023 | 458,000.00 |
| Jun 30, 2023 | 778,000.00 |
| Mar 31, 2023 | 677,000.00 |
| Dec 31, 2022 | 545,000.00 |
| Sep 30, 2022 | 485,000.00 |
| Jun 30, 2022 | 588,000.00 |
| Mar 31, 2022 | 791,000.00 |
| Dec 31, 2021 | 162,000.00 |
| Sep 30, 2021 | 514,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Dec 31, 2020 | 121,000.00 |